ORIGINAL RESEARCH
Published on 11 Feb 2022
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
doi 10.3389/fimmu.2022.829670
- 3,343 views
- 11 citations
- Frontiers in Immunology
- Alloimmunity and Transplantation
- Research Topics
- Moving Towards Allogeneic Cellular Therapies: Opportunities and Challenges
Moving Towards Allogeneic Cellular Therapies: Opportunities and Challenges
41k
Total downloads
184k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CLINICAL TRIAL
Published on 15 Dec 2021
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
doi 10.3389/fimmu.2021.756495
- 3,142 views
- 14 citations
PERSPECTIVE
Published on 03 Aug 2021
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
doi 10.3389/fimmu.2021.695051
- 4,661 views
- 13 citations
ORIGINAL RESEARCH
Published on 22 Jul 2021
Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
doi 10.3389/fimmu.2021.690467
- 5,036 views
- 13 citations
REVIEW
Published on 10 Jun 2021
Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review
doi 10.3389/fimmu.2021.688460
- 7,502 views
- 16 citations
REVIEW
Published on 03 Mar 2021
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
doi 10.3389/fimmu.2021.640082
- 60,223 views
- 100 citations
ORIGINAL RESEARCH
Published on 29 Jan 2021
HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
doi 10.3389/fimmu.2020.586168
- 16,218 views
- 37 citations
REVIEW
Published on 08 Jan 2021
Allogeneic CAR Cell Therapy—More Than a Pipe Dream
doi 10.3389/fimmu.2020.618427
- 29,713 views
- 98 citations
ORIGINAL RESEARCH
Published on 08 Jan 2021
Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
doi 10.3389/fimmu.2020.598402
- 4,794 views
- 30 citations
REVIEW
Published on 11 Nov 2020
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells
doi 10.3389/fimmu.2020.583716
- 19,612 views
- 41 citations
REVIEW
Published on 21 Oct 2020
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation
doi 10.3389/fimmu.2020.583564
- 2,863 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Oct 2020
ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma
doi 10.3389/fimmu.2020.581468
- 4,129 views
- 30 citations
Published in
Frontiers in Immunology
- Alloimmunity and Transplantation
Impact
- 184kTopic views
- 140kArticle views
- 41kArticle downloads